Certified by Founder Lodge
Roca Therapeutics
France - Nice, Provence-Alpes-Côte d’Azur
START UP
1 Disclosed Funding Rounds $0
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
First In Class Drugs against diseases favored by hyper-vascularization and immuno-suppressive inflammation
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 26 ,2022 | Seed | Undisclosed Amount |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
XCENA | $135,000,000 | (Jun 2, 2026)
Voxmind | $735,203 | (Jun 2, 2026)
Human Archive (YC W26) | $8,200,000 | (Jun 2, 2026)
SpeedLabs | $6,500,000 | (Jun 2, 2026)
Invertix | $1,977,831 | (Jun 2, 2026)
